← Evidence map

ArticlePsychopharmacology2022

Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization.

Ramakrishna Nirogi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35298691